GLPwatch
Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
NCT03371862 · Withdrawn
Last updated 2026-05-28This clinical trial is testing whether the medication liraglutide can reduce the need for intravenous nutrition in people with short bowel syndrome.
Status Withdrawn Stopped before any participant enrolled.
Phase Phase 2 Tests whether it works and watches safety in a moderate group.
Type Interventional (clinical trial)
Design open-label (no blinding) treatment study
Who can join Ages 18+ · all sexes
Timeline Started 2017-10 · est. completion 2020-09
Where 1 site · United Kingdom
What this study is testing ClinicalTrials.gov NCT03371862 ↗
Description as written by the study sponsor.
Pilot study looking at the effect on Liraglutide in the reduction of parenteral support in patients with short bowel.
Treatments tested
- Liraglutide Pen Injector [Victoza] Drug
Pilot study of liraglutide in patients with short bowel.
| Main thing measured | Improvement in parenteral support |
|---|---|
| Sponsor | Imperial College London |
| Conditions studied | Short Bowel Syndrome |
| GLP-1 drugs | liraglutide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT03371862 ↗